Carolyn Sidor

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

Joseph P. Eder, Jeffrey G. Supko, Jeffrey W. Clark et al. · Journal of Clinical Oncology · 2002 · 245 citations

Medicine, Oncology, Pharmacology +16

Phase II Study of Recombinant Human Endostatin in Patients With Advanced Neuroendocrine Tumors

Matthew H. Kulke, Emily K. Bergsland, David P. Ryan et al. · Journal of Clinical Oncology · 2006 · 174 citations · Full text

Medicine, Oncology, Pharmacology +11

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

Christopher J. Sweeney, Glenn Liu, Constantin T. Yiannoutsos et al. · Clinical Cancer Research · 2005 · 173 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action

Graham C. Fletcher, Richard D. Brokx, Trisha A. Denny et al. · Molecular Cancer Therapeutics · 2010 · 131 citations

Medicine, Oncology, Pharmacology +17

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

J S James, Daryl J. Murry, Anthony M. Treston et al. · Investigational New Drugs · 2006 · 128 citations

Medicine, Oncology, Pharmacology +16